↓ Skip to main content

Dove Medical Press

Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study

Overview of attention for article published in Infection and Drug Resistance, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#27 of 2,050)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
6 news outlets
policy
3 policy sources
twitter
4 X users

Citations

dimensions_citation
76 Dimensions

Readers on

mendeley
226 Mendeley
Title
Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study
Published in
Infection and Drug Resistance, February 2021
DOI 10.2147/idr.s287792
Pubmed ID
Authors

Ilinca A Dutescu, Sean A Hillier

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 226 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 226 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 10%
Student > Ph. D. Student 21 9%
Student > Master 18 8%
Researcher 17 8%
Student > Doctoral Student 11 5%
Other 27 12%
Unknown 109 48%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 28 12%
Medicine and Dentistry 14 6%
Pharmacology, Toxicology and Pharmaceutical Science 12 5%
Chemistry 12 5%
Social Sciences 7 3%
Other 39 17%
Unknown 114 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 60. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2024.
All research outputs
#712,675
of 25,525,181 outputs
Outputs from Infection and Drug Resistance
#27
of 2,050 outputs
Outputs of similar age
#20,607
of 528,503 outputs
Outputs of similar age from Infection and Drug Resistance
#3
of 74 outputs
Altmetric has tracked 25,525,181 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,050 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 528,503 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.